genOway grants the leading UK academic research funder a non-exclusive license for CRISPR/Cas9 technology
Lyon, France (ots/PRNewswire) - genOway, a world leader in the field of genetically modified innovative research models, announced today that it has granted a non-exclusive CRISPR/Cas9 license to the most important funding institution of biomedical academic research in the United Kingdom. In December 2018, genOway ...